A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body - Join Clinical Trial NCTNCT06421636
How to Join This Clinical Trial - NCTNCT06421636
Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-Transfusion Dependent Beta-Thalassemia (NTDT). This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Non-Transfusion Dependent Beta-Thalassemia (NTDT). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Non-Transfusion Dependent Beta-Thalassemia (NTDT)
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06421636 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 21 locations. Find a study site near you:
Clinical Research Site
New York, New York 10065 - United States
Status: RECRUITING
Clinical Research Site
Tbilisi, 0159 - Georgia
Status: RECRUITING
Clinical Research Site
Tbilisi, 0160 - Georgia
Status: RECRUITING
Clinical Research Site
New Delhi, Delhi 110029 - India
Status: RECRUITING
Clinical Research Site
Ahmedabad, Gujarat 380009 - India
Status: RECRUITING
Clinical Research Site
Surat, Gujarat 395002 - India
Status: RECRUITING
Clinical Research Site
Kochi, Kerala 682041 - India
Status: RECRUITING
Clinical Research Site
Mumbai, Maharashtra 400022 - India
Status: RECRUITING
Clinical Research Site
Jaipur, Rajasthan 302004 - India
Status: RECRUITING
Clinical Research Site
Delhi, 110048 - India
Status: RECRUITING
And 11 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Non-Transfusion Dependent Beta-Thalassemia (NTDT):
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships